Innovation today, healthier tomorrows

What's New

More

RSS

2017.01.14
R&D
PDF/184KB
Sunovion Announces Pivotal Study Results for Novel Drug Candidate Dasotraline Demonstrating Significantly Improved Attention Deficit Hyperactivity Disorder Symptoms in Children Compared to Placebo
2017.01.13
R&D
PDF/240KB
Sunovion Announces Top-line Results from Studies Evaluating Dasotraline in Adults with Binge Eating Disorder and Attention Deficit Hyperactivity Disorder
2016.12.26
Corporate
 
Posted Conference Call for Acquisition of Tolero Pharmaceuticals, Inc. [Webcast]
2016.12.26
Licensing
PDF/112KB
Sumitomo Dainippon Pharma to Conduct Meropenem Business in Five Countries of South-East Asia and Hong Kong
2016.12.22
Licensing
PDF/153KB
Sunovion Enters into License Agreement for Three Approved Treatment Options for People with COPD in the U.S.
2016.12.21
Corporate
PDF/986KB
Teleconference Material (Acquisition of Tolero Pharmaceuticals, Inc.)